Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy — Stella

Recruiting

Back to Radiotherapy-induced Nausea and Vomiting (RINV) trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Chongqing University Cancer Hospital, Chongqing, Chongqing Municipality

Key details

Phase

Post-approval study

Sponsor

Chongqing University Cancer Hospital

Enrollment target

~60 participants

Started

March 2025

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

1 Year – 14 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov